NCT03907722View on ClinicalTrials.gov

The 3q25 rs2305619 Polymorphism Associates With Microvascular Obstruction in STEMI

CompletedOBSERVATIONAL
Enrollment

217

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

August 2, 2018

Study Completion Date

September 3, 2018

Conditions
STEMIMicrovascular Coronary Artery Disease
Interventions
OTHER

Long pentraxin 3

Primary PCI

Trial Locations (1)

11420

Indonesian Cardiovascular Research Center, Jakarta

All Listed Sponsors
lead

Indonesian Cardiovascular Research Center

OTHER

NCT03907722 - The 3q25 rs2305619 Polymorphism Associates With Microvascular Obstruction in STEMI | Biotech Hunter | Biotech Hunter